학술논문
Atezolizumab with or without bevacizumab and platinum-pemetrexed in patients with stage IIIB/IV non-squamous non-small cell lung cancer with EGFR mutation, ALK rearrangement or ROS1 fusion progressing after targeted therapies: A multicentre phase II open-label non-randomised study GFPC 06-2018
Document Type
Article
Author
Bylicki, O.; Tomasini, P.; Greillier, L.; Radj, G.; Guisier, F.; Chouaid, C.; Monnet, I.; Ricordel, C.; Bigay-Game, L.; Geier, M.; Daniel, C.; Swalduz, A.; Toffart, A.-C.; Doubre, H.; Peloni, J.-M.; Moreau, D.; Subtil, F.; Martins-Lavinas, P.-H.; Grellard, J.-M.; Castera, M.; Clarisse, B.; Decroisette, C.
Source
In: European Journal of Cancer . (European Journal of Cancer, April 2023, 183:38-48)
Subject
Language
English
ISSN
18790852
09598049
09598049